Open AccessIs It Too Much of a Good Thing? A New Era in Phosphate Binder Therapy in ESRD
Author(s) -
Wajeh Y. Qunibi
Publication year - 2015
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2015020135
Subject(s) - hyperphosphatemia , phosphate binder , medicine , sevelamer , anemia , lanthanum carbonate , secondary hyperparathyroidism , intensive care medicine , kidney disease , calcium , parathyroid hormone
Hyperphosphatemia and anemia are common complications in patients with advanced CKD, and both contribute to their increased morbidity and mortality from cardiovascular disease. Fortunately, both conditions can be effectively treated with currently available therapeutic agents: phosphate binders,
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom